Oscar Health, Inc. - COMMON STOCK (OSCR)

Historical Holders from Q1 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
OSCR on NYSE
Shares outstanding
224,919,027
Price per share
$14.38
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
149,549,352
Total reported value
$2,830,944,163
% of total 13F portfolios
0.01%
Share change
-18,939,968
Value change
-$427,166,462
Number of holders
329
Price from insider filings
$14.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oscar Health, Inc. - COMMON STOCK (OSCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.4% $182,218,163 13,941,711 BlackRock, Inc. 30 Jun 2025
JPMORGAN CHASE & CO 4.5% -32% $130,056,812 -$50,451,951 9,950,789 -28% JPMORGAN CHASE & CO. 30 Jun 2025
T. Rowe Price Investment Management, Inc. 3.7% $157,535,536 8,322,004 T. Rowe Price Investment Management, Inc. 30 Sep 2025
As of 30 Sep 2025, Oscar Health, Inc. - COMMON STOCK (OSCR) has 329 institutional shareholders filing 13F forms. They hold 149,549,352 shares. of 224,919,027 outstanding shares (66%) .

Top 25 institutional shareholders own 50% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9% 20,160,399 +2.1% 0.01% $381,636,353
BlackRock, Inc. 7.2% 16,186,352 +2.7% 0.01% $306,407,651
T. Rowe Price Investment Management, Inc. 3.7% 8,307,496 -34% 0.1% $157,261,000
Thrive Capital Management, LLC 2.8% 6,343,617 0% 25% $120,084,670
AMERICAN CENTURY COMPANIES INC 2.4% 5,298,340 +89% 0.05% $100,297,576
STATE STREET CORP 2.3% 5,131,849 -5% 0% $97,145,902
MORGAN STANLEY 2.1% 4,770,288 +74% 0.01% $90,301,570
GEODE CAPITAL MANAGEMENT, LLC 2.1% 4,681,883 +3.9% 0.01% $88,641,210
CITADEL ADVISORS LLC 1.9% 4,287,208 +114% 0.07% $81,156,848
DIMENSIONAL FUND ADVISORS LP 1.7% 3,718,765 +0.86% 0.02% $70,399,629
FARALLON CAPITAL MANAGEMENT LLC 1.6% 3,639,000 +147% 0.39% $68,886,270
Capital World Investors 1.6% 3,622,586 0% 0.01% $68,575,553
PRICE T ROWE ASSOCIATES INC /MD/ 1.3% 2,999,618 +341% 0.01% $56,783,000
GLYNN CAPITAL MANAGEMENT LLC 1.3% 2,856,025 -5.1% 17% $54,064,553
UBS Group AG 1.1% 2,510,470 +155% 0.01% $47,523,197
JPMORGAN CHASE & CO 1.1% 2,476,645 -75% 0% $46,882,908
GOLDMAN SACHS GROUP INC 0.98% 2,211,242 +4.4% 0.01% $41,858,811
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.87% 1,948,418 -11% 0.05% $36,883,553
NORTHERN TRUST CORP 0.82% 1,835,394 +4% 0% $34,744,008
JANE STREET GROUP, LLC 0.79% 1,768,955 +493% 0.04% $33,486,318
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 1,719,168 +4.6% 0.01% $32,543,850
TUDOR INVESTMENT CORP ET AL 0.74% 1,669,198 +180% 0.2% $31,597,918
D. E. Shaw & Co., Inc. 0.71% 1,586,859 +74% 0.02% $30,039,241
HRT FINANCIAL LP 0.68% 1,518,643 +180% 0.11% $28,747,000
STATE OF MICHIGAN RETIREMENT SYSTEM 0.64% 1,450,000 0.13% $27,448,500

Institutional Holders of Oscar Health, Inc. - COMMON STOCK (OSCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,590,816 $22,918,223 +$20,545,862 $14.38 7
2025 Q3 149,549,352 $2,830,944,163 -$427,166,462 $18.93 329
2025 Q2 168,548,889 $3,611,647,706 -$289,635,005 $21.44 323
2025 Q1 186,598,534 $2,446,655,411 -$110,044,412 $13.11 284
2024 Q4 194,763,906 $2,618,996,411 +$144,258,565 $13.44 256
2024 Q3 178,386,882 $3,782,103,247 +$110,509,431 $21.21 281
2024 Q2 172,602,703 $2,730,922,724 +$252,355,411 $15.82 260
2024 Q1 156,903,935 $2,334,180,973 +$181,115,233 $14.87 218
2023 Q4 62,955 $576,039 +$9,736 $9.15 1
2023 Q3 147,067,200 $819,527,393 -$7,478,127 $5.57 174
2023 Q2 148,010,019 $1,192,835,509 +$4,854,252 $8.06 161
2023 Q1 147,420,997 $964,131,057 +$67,252,698 $6.54 128
2022 Q4 139,313,215 $342,705,966 -$15,171,398 $2.46 125
2022 Q3 146,204,584 $729,574,689 +$26,500,708 $4.99 124
2022 Q2 141,753,132 $602,485,657 -$91,984,837 $4.25 121
2022 Q1 143,205,669 $1,427,870,402 +$13,287,047 $9.97 118
2021 Q4 129,426,020 $1,016,027,676 +$32,521,642 $7.85 102
2021 Q3 125,732,628 $2,181,616,000 -$93,239,849 $17.39 85
2021 Q2 121,627,326 $2,629,248,000 -$56,484,703 $21.50 73
2021 Q1 136,276,378 $3,642,646,000 +$3,328,016,782 $26.88 86